Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120


Evidence for an immune barrier after in utero hematopoietic-cell transplantation.

Peranteau WH, Endo M, Adibe OO, Flake AW.

Blood. 2007 Feb 1;109(3):1331-3. Epub 2006 Oct 5.


Stable long-term mixed chimerism achieved in a canine model of allogeneic in utero hematopoietic cell transplantation.

Vrecenak JD, Pearson EG, Santore MT, Todorow CA, Li H, Radu A, Bhatti T, Peranteau WH, Johnson MP, Flake AW.

Blood. 2014 Sep 18;124(12):1987-95. doi: 10.1182/blood-2013-11-537571. Epub 2014 May 28.


CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation.

Peranteau WH, Endo M, Adibe OO, Merchant A, Zoltick PW, Flake AW.

Blood. 2006 Dec 15;108(13):4268-74. Epub 2006 Sep 5.


Maternal alloantibodies induce a postnatal immune response that limits engraftment following in utero hematopoietic cell transplantation in mice.

Merianos DJ, Tiblad E, Santore MT, Todorow CA, Laje P, Endo M, Zoltick PW, Flake AW.

J Clin Invest. 2009 Sep;119(9):2590-600. doi: 10.1172/JCI38979. Epub 2009 Aug 3.


Facilitating cells enable engraftment of purified fetal liver stem cells in allogeneic recipients.

Gaines BA, Colson YL, Kaufman CL, Ildstad S.

Exp Hematol. 1996 Jul;24(8):902-13.


Haploidentical in utero hematopoietic cell transplantation improves phenotype and can induce tolerance for postnatal same-donor transplants in the canine leukocyte adhesion deficiency model.

Peranteau WH, Heaton TE, Gu YC, Volk SW, Bauer TR, Alcorn K, Tuschong LM, Johnson MP, Hickstein DD, Flake AW.

Biol Blood Marrow Transplant. 2009 Mar;15(3):293-305. doi: 10.1016/j.bbmt.2008.11.034.


Early chimerism threshold predicts sustained engraftment and NK-cell tolerance in prenatal allogeneic chimeras.

Durkin ET, Jones KA, Rajesh D, Shaaban AF.

Blood. 2008 Dec 15;112(13):5245-53. doi: 10.1182/blood-2007-12-128116. Epub 2008 Sep 16.


In utero depletion of fetal hematopoietic stem cells improves engraftment after neonatal transplantation in mice.

Derderian SC, Togarrati PP, King C, Moradi PW, Reynaud D, Czechowicz A, Weissman IL, MacKenzie TC.

Blood. 2014 Aug 7;124(6):973-80. doi: 10.1182/blood-2014-02-550327. Epub 2014 May 30.


Enhanced in utero allogeneic engraftment in mice after mobilizing fetal HSCs by α4β1/7 inhibition.

Kim AG, Vrecenak JD, Boelig MM, Eissenberg L, Rettig MP, Riley JS, Holt MS, Conner MA, Loukogeorgakis SP, Li H, DiPersio JF, Flake AW, Peranteau WH.

Blood. 2016 Nov 17;128(20):2457-2461. Epub 2016 Sep 20.


Correction of murine hemoglobinopathies by prenatal tolerance induction and postnatal nonmyeloablative allogeneic BM transplants.

Peranteau WH, Hayashi S, Abdulmalik O, Chen Q, Merchant A, Asakura T, Flake AW.

Blood. 2015 Sep 3;126(10):1245-54. doi: 10.1182/blood-2015-03-636803. Epub 2015 Jun 29.


In utero hematopoietic stem cell transplantation: progress toward clinical application.

Merianos D, Heaton T, Flake AW.

Biol Blood Marrow Transplant. 2008 Jul;14(7):729-40. doi: 10.1016/j.bbmt.2008.02.012. Epub 2008 Apr 25. Review.


Cellular therapies supplement: the peritoneum as an ectopic site of hematopoiesis following in utero transplantation.

Muench MO, Chen JC, Beyer AI, Fomin ME.

Transfusion. 2011 Nov;51 Suppl 4:106S-117S. doi: 10.1111/j.1537-2995.2011.03373.x.


Donor major histocompatibility complex class I expression determines the outcome of prenatal transplantation.

Durkin ET, Jones KA, Elnaggar D, Shaaban AF.

J Pediatr Surg. 2008 Jun;43(6):1142-7. doi: 10.1016/j.jpedsurg.2008.02.046.


Supplemental Content

Support Center